PLx Pharma Inc. License Agreements
7 Contracts & Agreements
- AMENDED AND RESTATED PATENT LICENSE AGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM AND PLX PHARMA INC. DATED DECEMBER 11, 2009 TABLE OF CONTENTS (Filed With SEC on August 15, 2017)
- AMENDED AND RESTATED PATENT LICENSE AGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM AND PLX PHARMA INC. DATED DECEMBER 11, 2009 TABLE OF CONTENTS (Filed With SEC on June 12, 2017)
- AMENDEDAND RESTATED LICENSE& COMMERCIALIZATION AGREEMENT by and between LEE’SPHARMACEUTICAL holdings Limited, ZhaokePharmaceutical (HEFEI) Co. Ltd., lee’spharmaceutical (... (Filed With SEC on January 5, 2016)
- AMENDEDAND RESTATED LICENSE& COMMERCIALIZATION AGREEMENT by and between LEE’SPHARMACEUTICAL holdings Limited, ZhaokePharmaceutical (HEFEI) Co. Ltd., lee’spharmaceutical (... (Filed With SEC on October 5, 2015)
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on February 6, 2014)
- SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on February 6, 2014)
- LICENSE AGREEMENT REGARDING MAGAININ PEPTIDE (Filed With SEC on February 6, 2014)
